These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28772340)

  • 1. Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case-control study.
    Hui RWH; Seto WK; Cheung KS; Mak LY; Liu KSH; Fung J; Wong DK; Lai CL; Yuen MF
    J Viral Hepat; 2018 Jan; 25(1):97-104. PubMed ID: 28772340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B.
    Seto WK; Hui RWH; Mak LY; Fung J; Cheung KS; Liu KSH; Wong DK; Lai CL; Yuen MF
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):575-583.e2. PubMed ID: 28970146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B.
    Mak LY; Hui RW; Fung J; Liu F; Wong DK; Cheung KS; Yuen MF; Seto WK
    J Hepatol; 2020 Oct; 73(4):800-806. PubMed ID: 32504663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.
    Peng D; Han Y; Ding H; Wei L
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1082-8. PubMed ID: 18707599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters.
    Rastogi A; Sakhuja P; Kumar A; Hissar S; Jain A; Gondal R; Sarin SK
    Indian J Pathol Microbiol; 2011; 54(3):454-9. PubMed ID: 21934202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatic steatosis in chronic hepatitis B patients and its association with disease severity.
    Lesmana LA; Lesmana CR; Pakasi LS; Krisnuhoni E
    Acta Med Indones; 2012 Jan; 44(1):35-9. PubMed ID: 22451183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factors.
    Minakari M; Molaei M; Shalmani HM; Mohammad Alizadeh AH; Jazi AH; Naderi N; Shavakhi A; Mashayekhi R; Zali MR
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):512-6. PubMed ID: 19190500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B.
    Wong SW; Chan WK; Mohamed R
    J Viral Hepat; 2020 Dec; 27(12):1297-1305. PubMed ID: 32668489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection.
    Mak LY; Hui RW; Fung J; Liu F; Wong DK; Li B; Cheung KS; Yuen MF; Seto WK
    Hepatol Int; 2021 Aug; 15(4):901-911. PubMed ID: 34152534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body-mass index is associated with fibrosis regression during long-term nucleoside analogue therapy in chronic hepatitis B.
    Seto WK; Fung J; Cheung KS; Mak LY; Hui RW; Liu KS; Lai CL; Yuen MF
    Aliment Pharmacol Ther; 2016 Nov; 44(10):1071-1079. PubMed ID: 27659292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].
    Mi YQ; Liu YG; Xu L; Fan JG; Zhang H; Ping L; Shi RF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.
    Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1842-8. PubMed ID: 23829381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B.
    Xu L; Lu W; Li P; Shen F; Mi YQ; Fan JG
    Dig Liver Dis; 2017 Aug; 49(8):910-917. PubMed ID: 28433586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long-term nucleoside analogue.
    Mak LY; Lee CH; Cheung KS; Wong DK; Liu F; Hui RW; Fung J; Xu A; Lam KS; Yuen MF; Seto WK
    Liver Int; 2019 Jul; 39(7):1217-1225. PubMed ID: 30912255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and virological characteristics of chronic hepatitis B patients with hepatic steatosis.
    Zheng RD; Chen JN; Zhuang QY; Lu YH; Chen J; Chen BF
    Int J Med Sci; 2013; 10(5):641-6. PubMed ID: 23569427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A diagnostic algorithm for assessment of liver fibrosis by liver stiffness measurement in patients with chronic hepatitis B.
    Cai YJ; Dong JJ; Wang XD; Huang SS; Chen RC; Chen Y; Wang YQ; Song M; Chen YP; Li Z; Zhou MT; Shi KQ
    J Viral Hepat; 2017 Nov; 24(11):1005-1015. PubMed ID: 28419755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatic steatosis: a common reason for elevated alanine aminotransferase levels in HBsAg-positive chronic hepatitis B patients with low HBV DNA loads].
    Shi JP; Fan JG; Lou GQ; Zhang L; Hu CB; Wu R; Xun YH
    Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):818-22. PubMed ID: 19032864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate to severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis.
    Shen F; Mi YQ; Xu L; Liu YG; Wang XY; Pan Q; Zhang RN; Hu XQ; Xu LM; Fan JG
    Aliment Pharmacol Ther; 2019 Jul; 50(1):93-102. PubMed ID: 31094016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Chan WK; Nik Mustapha NR; Mahadeva S
    J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.